BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,900 shares, a growth of 58.3% from the September 15th total of 1,200 shares. Based on an average trading volume of 1,600 shares, the short-interest ratio is presently 1.2 days.
BioSyent Price Performance
Shares of BioSyent stock remained flat at $7.75 during trading on Monday. BioSyent has a 12-month low of $5.65 and a 12-month high of $8.90. The company’s 50-day simple moving average is $7.79 and its two-hundred day simple moving average is $7.15.
BioSyent Increases Dividend
The firm also recently announced a dividend, which was paid on Sunday, September 15th. Stockholders of record on Thursday, September 5th were paid a $0.0334 dividend. This represents a dividend yield of 1.72%. The ex-dividend date of this dividend was Wednesday, September 4th. This is a positive change from BioSyent’s previous dividend of $0.03.
About BioSyent
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Read More
- Five stocks we like better than BioSyent
- Profitably Trade Stocks at 52-Week Highs
- Nike Stock: Ready to Slingshot Higher as New CEO Takes the Helm
- Short Selling: How to Short a Stock
- 2 Stocks Riding the Recovery in Cloud Computing Driven by AI
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Champion Homes: The Focus on Affordability Makes It a Winner
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.